Integrating tacrolimus into eutectic oil-based microemulsion for atopic dermatitis: simultaneously enhancing percutaneous delivery and treatment efficacy with relieving side effects

References

• Dubrac S, Schmuth M, Ebner S. Atopic dermatitis: the role of langerhans cells in disease pathogenesis. Immuno Cell Biol. 2010;88(4):400–409. doi:10.1038/icb.2010.33
   PubMed Web of Science ®Google Scholar
• Heratizadeh A, Werfel T, Wollenberg A, et al. Effects of structured patient education in adults with atopic dermatitis: multicenter randomized controlled trial. J Allergy Clin Iimmunol. 2017;140(3):845–853. doi:10.1016/j.jaci.2017.01.029
   PubMed Web of Science ®Google Scholar
• Alyoussef A. Blocking TGF-beta type 1 receptor partially reversed skin tissue damage in experimentally induced atopic dermatitis in mice. Cytokine. 2018;106:45–53. doi:10.1016/j.cyto.2018.02.02529549723
   PubMed Web of Science ®Google Scholar
• Odhiambo JA, Williams HC, Clayton TO, Robertson CF, Asher MI. Global variations in prevalence of eczema symptoms in children from ISAAC phase three. J Allergy Clin Immunol. 2009;124(6):1251–1258. doi:10.1016/j.jaci.2009.10.00920004783
   PubMed Web of Science ®Google Scholar
• Mesquita Kde C, Igreja AC, Costa IM. Atopic dermatitis and vitamin D: facts and controversies. An Bras Dermatol. 2013;88(6):945–953. doi:10.1590/abd1806-4841.2013266024474104
   PubMedGoogle Scholar
• Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis. Int J Pharm. 2010;398(1–2):165–178. doi:10.1016/j.ijpharm.2010.07.00820637847
   PubMedGoogle Scholar
• Schauber J, Weisenseel P, Ruzicka T. Topical treatment of perianal eczema with tacrolimus 0.1%. Br J Dermatol. 2009;16(6):1384–1386. doi:10.1111/j.1365-2133.2009.09345.x
   Google Scholar
• Czarnecka-Operacz M, Jenerowicz D. Topical calcineurin inhibitors in the treatment of atopic dermatitis - an update on safety issues. J Dtsch Dermatol Ges. 2012;10(3):167–172. doi:10.1111/j.1610-0387.2011.07791.x21974750
   PubMed Web of Science ®Google Scholar
• Pan W, Qin M, Zhang G, et al. Combination of hydrotropic nicotinamide with nanoparticles for enhancing tacrolimus percutaneous delivery. Int J Nanomedicine. 2016;11:4037–4050. doi:10.2147/IJN.S10854527578973
   PubMedGoogle Scholar
• Wan T, Pan J, Long Y, et al. Dual roles of TPGS based microemulsion for tacrolimus: enhancing the percutaneous delivery and anti-psoriatic efficacy. Int J Pharm. 2017;528(1–2):511–523. doi:10.1016/j.ijpharm.2017.06.05028629978
   PubMedGoogle Scholar
• Andrade LM, Silva LAD, Krawczyk-Santos AP, et al. Improved tacrolimus skin permeation by co-encapsulation with clobetasol in lipid nanoparticles: study of drug effects in lipid matrix by electron paramagnetic resonance. Eur J Pharm Biopharm. 2017;119:142–149. doi:10.1016/j.ejpb.2017.06.01428627400
   PubMed Web of Science ®Google Scholar
• Li G, Fan Y, Fan C, et al. Tacrolimus-loaded ethosomes: physicochemical characterization and in vivo evaluation. Eur J Pharm Biopharm. 2012;82(1):49–57. doi:10.1016/j.ejpb.2012.05.01122705640
   PubMed Web of Science ®Google Scholar
• Tessema EN, Gebre-Mariam T, Paulos G, Wohlrab J, Neubert RHH. Delivery of oat-derived phytoceramides into the stratum corneum of the skin using nanocarriers: formulation, characterization and in vitro and ex-vivo penetration studies. Eur J Pharm Biopharm. 2018;127:260–269. doi:10.1016/j.ejpb.2018.02.03729501672
   PubMed Web of Science ®Google Scholar
• Zhuo F, Abourehab MAS, Hussain Z. Hyaluronic acid decorated tacrolimus-loaded nanoparticles: efficient approach to maximize dermal targeting and anti-dermatitis efficacy. Carbohydr Polym. 2018;197:478–489. doi:10.1016/j.carbpol.2018.06.02330007638
   PubMed Web of Science ®Google Scholar
• Kiselmann C, Dobler D, Schmidts T, et al. Development of a skin-friendly microemulsion for dermal allergen-speicific immunotherapy. Int J Pharm. 2018;550(1–2):463–469. doi:10.1016/j.ijpharm.2018.09.00230194011
   PubMed Web of Science ®Google Scholar
• Zhang J, Michniak-Kohn BB. Investigation of microemulsion and microemulsion gel formulations for dermal delivery of clotrimazole. Int J Pharm. 2018;536(1):345–352. doi:10.1016/j.ijpharm.2017.11.04129170117
   PubMedGoogle Scholar
• Kirsner RS, Heffernan MP, Antaya R. Safety and efficacy of tacrolimus ointment versus pimecrolimus cream in the treatment of patients with atopic dermatitis previously treated with corticosteroids. Acta Derm Venereol. 2010;90(1):58–64. doi:10.2340/00015555-074820107727
   PubMed Web of Science ®Google Scholar
• Pople PV, Singh KK. Targeting tacrolimus to deeper layers of skin with improved safety for treatment of atopic dermatitis-part II: in vivo assessment of dermatopharmacokinetics, biodistribution and efficacy. Int J Pharm. 2012;434(1–2):70–79. doi:10.1016/j.ijpharm.2012.04.05122609427
   PubMedGoogle Scholar
• Yamanaka M, Yokota S, Iwao Y, Noguchi S, Itai S. Development and evaluation of a tacrolimus cream formulation using a binary solvent system. Int J Pharm. 2014;464(1–2):19–26. doi:10.1016/j.ijpharm.2014.01.01724456671
   PubMedGoogle Scholar
• Kita T, Uchida K, Kato K, Suzuki Y, Tominaga M, Yamazaki J. FK506 (tacrolimus) causes pain sensation through the activation of transient receptor potential ankyrin 1 (TRPA1) channels. J Physiol Sci. 2019;69(2):305–316.T. doi:10.1007/s12576-018-0647-z30478741
   PubMedGoogle Scholar
• Stander S, Stander H, Seeliger S, Luger TA, Steinhoff M. Topical pimecrolimus and tacrolimus transiently induce neuropeptide release and mast cell degranulation in murine skin. Br J Dermatol. 2007;156(5):1020–1026. doi:10.1111/j.1365-2133.2007.07813.x17388925
   PubMed Web of Science ®Google Scholar
• Wong LS, Otsuka A, Yamamoto Y, et al. TRPA1 channel participates in tacrolimus-induced pruritus in a chronic contact hypersensitivity murine model. J Dermatol Sci. 2018;89(2):207–209. doi:10.1016/j.jdermsci.2017.10.01229128286
   PubMedGoogle Scholar
• Ohtsuki M, Morimoto H, Nakagawa H. Tacrolimus ointment for the treatment of adult and pediatric atopic dermatitis: review on safety and benefits. J Dermatol. 2018;45(8):936–942. doi:10.1111/1346-8138.1450129927498
   PubMed Web of Science ®Google Scholar
• Kamatou GP, Vermaak I, Viljoen AM, Lawrence BM. Menthol: a simple monoterpene with remarkable biological properties. Phytochemistry. 2013;96:15–25. doi:10.1016/j.phytochem.2013.08.00524054028
   PubMed Web of Science ®Google Scholar
• Klein AH, Sawyer CM, Takechi K, et al. Topical hindpaw application of L-menthol decreases responsiveness to heat with biphasic effects on cold sensitivity of rat lumbar dorsal horn neurons. Neuroscience. 2012;219:234–242. doi:10.1016/j.neuroscience.2012.05.06122687951
   PubMedGoogle Scholar
• Xavier-Junior FH, Vauthier C, Morais AR, Alencar EN, Egito ES. Microemulsion systems containing bioactive natural oils: an overview on the state of the art. Drug Dev Ind Pharm. 2017;43(5):700–714. doi:10.1080/03639045.2016.123518627622950
   PubMed Web of Science ®Google Scholar
• Lucaciu OC, Connell GP. Itch sensation through transient receptor potential channels: a systematic review and relevance to manual therapy. J Manipulative Physiol Ther. 2013;36(6):385–393. doi:10.1016/j.jmpt.2013.05.01823896168
   PubMedGoogle Scholar
• Mizumura K, Koda H. Potentiation and suppression of the histamine response by raising and lowering the temperature in canine visceral polymodal receptors in vitro. Neurosci Lett. 1999;266:9–12.10336171
   PubMed Web of Science ®Google Scholar
• Haught JM, Jukic DM, English JC 3rd. Hydroxyethyl starch-induced pruritus relieved by a combination of menthol and camphor. J Am Acad Dermatol. 2008;59(1):151–153. doi:10.1016/j.jaad.2008.03.03418455262
   PubMedGoogle Scholar
• Metz M, Staubach P. Itch management: topical agents. Curr Probl Dermatol. 2016;50:40–45. doi:10.1159/00044604027578070
   PubMedGoogle Scholar
• Patel T, Ishiuji Y, Yosipovitch G. Menthol: a refreshing look at this ancient compound. J Am Acad Dermatol. 2007;57(5):873–878. doi:10.1016/j.jaad.2007.04.00817498839
   PubMed Web of Science ®Google Scholar
• Gohel MC, Nagori SA. Resolving issues of content uniformity and low permeability using eutectic blend of camphor and menthol. Indian J Pharm Sci. 2009;71(6):622–629. doi:10.4103/0250-474X.5954320376214
   PubMedGoogle Scholar
• Yu K, Wang Y, Wan T, et al. Tacrolimus nanoparticles based on chitosan combined with nicotinamide: enhancing percutaneous delivery and treatment efficacy for atopic dermatitis and reducing dose. Int J Nanomedicine. 2017;13:129–142. doi:10.2147/IJN.S15031929317821
   PubMed Web of Science ®Google Scholar
• SaviĆ V, TodosijeviĆ M, IliĆ T, et al. Tacrolimus loaded biocompatible lecithin-based microemulsions with improved skin penetration: structure characterization and in vitro/in vivo performances. Int J Pharm. 2017;529(1–2):491–505. doi:10.1016/j.ijpharm.2017.07.03628711641
   PubMedGoogle Scholar
• Patel P, Patel H, Panchal S, Mehta T. Formulation strategies for drug delivery of tacrolimus: an overview. Int J Pharm Investig. 2012;2(4):169–175. doi:10.4103/2230-973X.106981
   PubMedGoogle Scholar
• Lee SG, Kang JB, Kim SR, et al. Enhanced topical delivery of tacrolimus by a carbomer hydrogel formulation with transcutol P. Drug Dev Ind Pharm. 2016;42(10):1636–1642. doi:10.3109/03639045.2016.116010726925849
   PubMed Web of Science ®Google Scholar
• Papier A, Strowd LC. Atopic dermatitis: a review of topical nonsteroid therapy. Drugs Context. 2018;7:212521. doi:10.7573/dic.21252129632548
   PubMedGoogle Scholar
• Choi YY, Kim MH, Lee H, et al. Cynanchum atratum inhibits the development of atopic dermatitis in 2,4-dinitrochlorobenzene-induced mice. Biomed Phaemacother. 2017;90:321–327. doi:10.1016/j.biopha.2017.03.065
   PubMed Web of Science ®Google Scholar
• Ibaraki H, Kanazawa T, Takashima Y, Okada H, Seta Y. Transdermal anti-nuclear kappaB siRNA therapy for atopic dermatitis using a combination of two kinds of functional oligopeptide. Int J Pharm. 2018;542(1–2):213–220. doi:10.1016/j.ijpharm.2018.03.02629551748
   PubMedGoogle Scholar
• Weidinger S, Novak N. Atopic dermatitis. Lancet. 2016;387:1109–1122. doi:10.1016/S0140-6736(15)00149-X26377142
   PubMed Web of Science ®Google Scholar
• Chan CC, Liou CJ, Xu PY, Set AL. Effect of dehydroepiandrosterone on atopic dermatitis-like skin lesions induced by 1-chloro-2,4-dinitrobenzene in mouse. JJ Dermatol Sci. 2013;72(2):149–157. doi:10.1016/j.jdermsci.2013.06.015
   PubMed Web of Science ®Google Scholar
• Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65(7):805–821. doi:10.1111/j.1398-9995.2010.01995.x20384615
   PubMedGoogle Scholar
• Yosipovitch G, Gold LF, Lebwohl MG, Silverberg JI, Tallman AM, Zane LT. Early relief of pruritus in atopic dermatitis with crisaborole ointment, a non-steroidal, phosphodiesterase 4 inhibitor. Acta Derm Venereol. 2018;98(5):484–489. doi:10.2340/00015555-289329363715
   PubMed Web of Science ®Google Scholar
• Inagaki N, Shiraishi N, Igeta K. Net AL. Depletion of substance P, a mechanism for inhibition of mouse scratching behavior by tacrolimus. Eur J Pharmacol. 2010;626(2–3):283–289.19818345
   PubMed Web of Science ®Google Scholar
• Maeno H, Kiyama H, Tohyama M. Distribution of the substance P receptor (NK-1 receptor) in the central nervous system. BrainRes Mol Brain Res. 1993;18(1–2):43–58. doi:10.1016/0169-328X(93)90172-L
   PubMed Web of Science ®Google Scholar
• Andersen HH, Melholt C, Hilborg SD, et al. Antipruritic effect of cold-induced and transient receptor potential-agonist-induced counter-irritation on histaminergic itch in humans. Acta Derm Venereol. 2017;97(1):63–67. doi:10.2340/00015555-244727141849
   PubMedGoogle Scholar
• Palkar R, Ongun S, Catich E, et al. Cooling relief of acute and chronic itch requires TRPM8 channels and neurons. J Invest Dermatol. 2018;138(6):1391–1399. doi:10.1016/j.jid.2017.12.02529288650
   PubMed Web of Science ®Google Scholar
• Pérez de Vega MJ, Gómez-Monterrey I, Ferrer-Montiel A, González-Muňiz R. Transient receptor potential melastatin 8 channel (TRPM8) modulation: cool entryway for treating pain and cancer. J Med Chem. 2016;59(22):10006–10029. doi:10.1021/acs.jmedchem.6b0030527437828
   PubMedGoogle Scholar